Development of donor specific antibodies after SARS-CoV-2 vaccination: What do we know so far?
Ahmed Daoud(Cairo University hospitals), Michael J. Casey, Karim Soliman(Medical University of South Carolina), Tibor Fülöp(Medical University of South Carolina), Maria Aurora Posadas Salas(Medical University of South Carolina), Sakshi Vaishnav, Ahmed A. Abdel-Kader, Genta Uehara(Medical University of South Carolina)
Cited by 0
Related Papers
A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider
|Patient Preference and Adherence|2022|156
Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study
|Molecular Psychiatry|2014|129
Defining Incident Chronic Kidney Disease in the Research Setting: The ARIC Study
|American Journal of Epidemiology|2009|119